OSA - 医索

【亿路同行公开课】Martin Heinz Dreyling教授：伊布替尼等靶向新药革新套细胞淋巴瘤治疗策略

Martin Heinz Dreyling教授Großadern医院/路德维希-马克西米利安-慕尼黑大学医学部教授MCL ESMO指南主要撰写者期刊编委Haematologica, Hematological Oncology, .......

学术资讯 - 临床医学

氯沙坦甚至减少了低危心血管患者的事件 Losartan Reduces Events Even in Low

当前位置：循环首页>正文氯沙坦甚至减少了低危心血管患者的事件Losartan Reduces Events Even in Low-risk CV Patients 作者:国际循环网日期:2005/8/29 0:00.....

学术资讯 - 临床医学

依那普利与氯沙坦极大增加了CABG的益处 Enalapril and Losartan Boost CABG Benefits

当前位置：循环首页>正文依那普利与氯沙坦极大增加了CABG的益处Enalapril and Losartan Boost CABG Benefits 作者:国际循环网日期:2005/8/11 0:00:00国际.......

学术资讯 - 临床医学

氯沙坦可降低高血压患者体内的锌水平 Losartan Reduces Zinc Levels in Hypertensive Patients

当前位置：循环首页>正文氯沙坦可降低高血压患者体内的锌水平Losartan Reduces Zinc Levels in Hypertensive Patients 作者:国际循环网日期:200.......

学术资讯 - 临床医学

氯沙坦可安全降低高血压学龄儿童的血压 Losartan Safely Lowers BP in Hypertensive School

当前位置：循环首页>正文氯沙坦可安全降低高血压学龄儿童的血压Losartan Safely Lowers BP in Hypertensive School-Age Children 作者:国际循环网 .......

学术资讯 - 临床医学

氯沙坦的卒中预防效应在亚组分析中得到证实 Losartan Stroke Prophylaxis Endures in Subgroup Analysis

当前位置：循环首页>正文氯沙坦的卒中预防效应在亚组分析中得到证实Losartan Stroke Prophylaxis Endures in Subgroup Analysis 作者:国际.......

学术资讯 - 临床医学

LIFE ISH研究：缬沙坦与氨替洛尔用于中风伴单纯收缩期高血压与左心室肥大患者的疗效对照研究

Department of Cardiology， Ullevaal University Hospital， Oslo， Norway.The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study reported that a losartan-based antihypertensive regimen red.....

学术资讯 - 临床研究

TNT：Treating to New Targets(TNT)Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease

New Eng J Med.2005; Early release Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease John C. LaRosa， et al.Background ：Previous trials have demonst.....

学术资讯 - 临床研究

LIFE Study：Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Wachtell K， Hornestam B， Lehto M， Slotwiner DJ， Gerdts E， Olsen MH， Aurup P， Dahlof B， Ibsen H.....

学术资讯 - 临床研究

COHERE：Rationale， design， and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians.

J Card Fail. 2000 Sep;6(3):264-71. Rationale， design， and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians. Franciosa .....

学术资讯 - 临床研究